These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 19508900)
21. Responses to antismoking radio and television advertisements among adult smokers and non-smokers across Africa: message-testing results from Senegal, Nigeria and Kenya. Perl R; Murukutla N; Occleston J; Bayly M; Lien M; Wakefield M; Mullin S Tob Control; 2015 Nov; 24(6):601-8. PubMed ID: 25184685 [TBL] [Abstract][Full Text] [Related]
22. A Randomized Phase II Trial of Pioglitazone for Lung Cancer Chemoprevention in High-Risk Current and Former Smokers. Keith RL; Blatchford PJ; Merrick DT; Bunn PA; Bagwell B; Dwyer-Nield LD; Jackson MK; Geraci MW; Miller YE Cancer Prev Res (Phila); 2019 Oct; 12(10):721-730. PubMed ID: 31308004 [TBL] [Abstract][Full Text] [Related]
24. Chemoprevention and screening for lung cancer: changing our focus to former smokers. Clamon G Clin Lung Cancer; 2015 Jan; 16(1):1-5. PubMed ID: 25454006 [TBL] [Abstract][Full Text] [Related]
25. The Effectiveness Of Social Media (Facebook) Compared With More Traditional Advertising Methods for Recruiting Eligible Participants To Health Research Studies: A Randomized, Controlled Clinical Trial. Frandsen M; Thow M; Ferguson SG JMIR Res Protoc; 2016 Aug; 5(3):e161. PubMed ID: 27511829 [TBL] [Abstract][Full Text] [Related]
26. Challenges and potential solutions to meeting accrual goals in a Phase II chemoprevention trial for prostate cancer. Kumar N; Crocker T; Smith T; Pow-Sang J; Spiess PE; Egan K; Quinn G; Schell M; Sebti S; Kazi A; Chuang T; Salup R; Helal M; Zagaja G; Trabulsi E; McLarty J; Fazili T; Williams CR; Schreiber F; Slaton J; Anderson JK Contemp Clin Trials; 2012 Mar; 33(2):279-85. PubMed ID: 22101219 [TBL] [Abstract][Full Text] [Related]
27. Pilot randomized phase II study of celecoxib in oral premalignant lesions. Papadimitrakopoulou VA; William WN; Dannenberg AJ; Lippman SM; Lee JJ; Ondrey FG; Peterson DE; Feng L; Atwell A; El-Naggar AK; Nathan CO; Helman JI; Du B; Yueh B; Boyle JO Clin Cancer Res; 2008 Apr; 14(7):2095-101. PubMed ID: 18381950 [TBL] [Abstract][Full Text] [Related]
28. Recruitment for an efficacy study in chemoprevention--the Concerned Smoker Study. Arnold A; Johnstone B; Stoskopf B; Skingley P; Browman G; Levine M; Hryniuk W Prev Med; 1989 Sep; 18(5):700-10. PubMed ID: 2694164 [TBL] [Abstract][Full Text] [Related]
29. Effectiveness and cost effectiveness of television, radio and print advertisements in promoting the New York smokers' quitline. Farrelly MC; Hussin A; Bauer UE Tob Control; 2007 Dec; 16 Suppl 1(Suppl 1):i21-3. PubMed ID: 18048625 [TBL] [Abstract][Full Text] [Related]
31. Strategies for recruitment to a population-based lung cancer prevention trial: the CARET experience with heavy smokers. Beta-Carotene and Retinol Efficacy Trial. Goodman GE; Valanis B; Meyskens FL; Williams JH; Metch BJ; Thornquist MD; Omenn GS Cancer Epidemiol Biomarkers Prev; 1998 May; 7(5):405-12. PubMed ID: 9610790 [TBL] [Abstract][Full Text] [Related]
32. Recruitment and accrual of women in a randomized controlled trial of spinal manipulation. Cambron JA J Manipulative Physiol Ther; 2001 Feb; 24(2):79-83. PubMed ID: 11208219 [TBL] [Abstract][Full Text] [Related]
33. Recruitment methods and costs for a randomized, placebo-controlled trial of chiropractic care for lumbar spinal stenosis: a single-site pilot study. Cambron JA; Dexheimer JM; Chang M; Cramer GD J Manipulative Physiol Ther; 2010 Jan; 33(1):56-61. PubMed ID: 20114101 [TBL] [Abstract][Full Text] [Related]
34. Chemoprevention strategies for patients with lung cancer in the context of screening. Saba NF; Khuri FR Clin Lung Cancer; 2005 Sep; 7(2):92-9. PubMed ID: 16179095 [TBL] [Abstract][Full Text] [Related]
35. The Use of Facebook Advertising to Recruit Healthy Elderly People for a Clinical Trial: Baseline Metrics. Cowie JM; Gurney ME JMIR Res Protoc; 2018 Jan; 7(1):e20. PubMed ID: 29367186 [TBL] [Abstract][Full Text] [Related]
36. Cost-effectiveness of aspirin, celecoxib, and calcium chemoprevention for colorectal cancer. Squires H; Tappenden P; Cooper K; Carroll C; Logan R; Hind D Clin Ther; 2011 Sep; 33(9):1289-305. PubMed ID: 21840057 [TBL] [Abstract][Full Text] [Related]
37. Proactive recruitment of cancer patients' social networks into a smoking cessation trial. Bastian LA; Fish LJ; Peterson BL; Biddle AK; Garst J; Lyna P; Molner S; Bepler G; Kelley M; Keefe FJ; McBride CM Contemp Clin Trials; 2011 Jul; 32(4):498-504. PubMed ID: 21382509 [TBL] [Abstract][Full Text] [Related]
39. Celecoxib modulates the capacity for prostaglandin E2 and interleukin-10 production in alveolar macrophages from active smokers. Mao JT; Roth MD; Serio KJ; Baratelli F; Zhu L; Holmes EC; Strieter RM; Dubinett SM Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5835-41. PubMed ID: 14676104 [TBL] [Abstract][Full Text] [Related]
40. Interest in an online smoking cessation program and effective recruitment strategies: results from Project Quit. McClure JB; Greene SM; Wiese C; Johnson KE; Alexander G; Strecher V J Med Internet Res; 2006 Aug; 8(3):e14. PubMed ID: 16954124 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]